U.S. Markets close in 5 hrs 37 mins

An Examination Of HAEMATO AG (FRA:HAE)

Simply Wall St

Building up an investment case requires looking at a stock holistically. Today I've chosen to put the spotlight on HAEMATO AG (FRA:HAE) due to its excellent fundamentals in more than one area. HAE is a company with great financial health as well as a an impressive track record of performance. Below, I've touched on some key aspects you should know on a high level. If you're interested in understanding beyond my broad commentary, read the full report on HAEMATO here.

Excellent balance sheet with solid track record

Over the past year, HAE has grown its earnings by 13%, with its most recent figure exceeding its annual average over the past five years. Not only did HAE outperformed its past performance, its growth also surpassed the Healthcare industry expansion, which generated a 12% earnings growth. This paints a buoyant picture for the company. HAE is financially robust, with ample cash on hand and short-term investments to meet upcoming liabilities. This suggests prudent control over cash and cost by management, which is a crucial insight into the health of the company. With a debt-to-equity ratio of 36%, HAE’s debt level is reasonable. This implies that HAE has a healthy balance between taking advantage of low cost debt funding as well as sufficient financial flexibility without succumbing to the strict terms of debt.

DB:HAE Income Statement, April 23rd 2019

Next Steps:

For HAEMATO, there are three fundamental aspects you should look at:

  1. Future Outlook: What are well-informed industry analysts predicting for HAE’s future growth? Take a look at our free research report of analyst consensus for HAE’s outlook.
  2. Valuation: What is HAE worth today? Is the stock undervalued, even when its growth outlook is factored into its intrinsic value? The intrinsic value infographic in our free research report helps visualize whether HAE is currently mispriced by the market.
  3. Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of HAE? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.